Sulforaphane promoted demethylation at the NRF2 promoter region, which leads to the activation of Nrf2 expression in Caco2 cells, suggesting the chemoprevention potential of sulforaphane in colon cancer [139]. The gene discussed is NFE2L2; the disease is colonic neoplasm.